OBJECTIVE: A national audit conducted in 2005/6 showed unacceptable quality of care for inpatients with inflammatory bowel disease (IBD) in the UK. This was re-audited in 2007/8 and 2010/11. The aim of this study is to examine the quality of care provided for inpatients with IBD in the UK. DESIGN: A programme of engagement and re-audit in 128 hospitals in the UK providing care for adult patients with IBD admitted to hospital between 1 June 2005 and 31 May 2006, 1 September 2007 and 31 August 2008 and 1 September 2010 and 31August 2011. INTERVENTIONS: Wide dissemination of the results, selected site visits, development of national service standards, and the development of an online document repository. MAIN OUTCOME MEASURES: Mortality, medical and surgical treatment, specialist nursing and dietetic care were audited. RESULTS: Data from 1953, 2016 and 1948 patients with ulcerative colitis (UC) and 2074, 2109 and 1900 patients with Crohn's disease (CD) were audited in 2005/6, 2007/8 and 2010/11, respectively. The mortality rate fell from 1.7% to 0.8% (p=0.034) in UC and from 1.3% to 0.8% (p=0.226) in CD. The proportion of inpatients reviewed by an IBD specialist nurse has risen from 23.7% to 44.9% in UC and from 18.1% to 39.9% (p<0.001) in CD. Anti-tumour necrosis factor therapy has increased in UC and CD (p<0.001) while ciclosporin prescription has slightly fallen in UC. Laparoscopic surgeries have significantly increased in UC and CD (p<0.001). CONCLUSIONS: The results show clear evidence of improvement in most aspects of the quality of care for IBD inpatients.
OBJECTIVE: A national audit conducted in 2005/6 showed unacceptable quality of care for inpatients with inflammatory bowel disease (IBD) in the UK. This was re-audited in 2007/8 and 2010/11. The aim of this study is to examine the quality of care provided for inpatients with IBD in the UK. DESIGN: A programme of engagement and re-audit in 128 hospitals in the UK providing care for adult patients with IBD admitted to hospital between 1 June 2005 and 31 May 2006, 1 September 2007 and 31 August 2008 and 1 September 2010 and 31August 2011. INTERVENTIONS: Wide dissemination of the results, selected site visits, development of national service standards, and the development of an online document repository. MAIN OUTCOME MEASURES: Mortality, medical and surgical treatment, specialist nursing and dietetic care were audited. RESULTS: Data from 1953, 2016 and 1948 patients with ulcerative colitis (UC) and 2074, 2109 and 1900 patients with Crohn's disease (CD) were audited in 2005/6, 2007/8 and 2010/11, respectively. The mortality rate fell from 1.7% to 0.8% (p=0.034) in UC and from 1.3% to 0.8% (p=0.226) in CD. The proportion of inpatients reviewed by an IBD specialist nurse has risen from 23.7% to 44.9% in UC and from 18.1% to 39.9% (p<0.001) in CD. Anti-tumour necrosis factor therapy has increased in UC and CD (p<0.001) while ciclosporin prescription has slightly fallen in UC. Laparoscopic surgeries have significantly increased in UC and CD (p<0.001). CONCLUSIONS: The results show clear evidence of improvement in most aspects of the quality of care for IBD inpatients.
Entities:
Keywords:
Crohn's Disease; Health Service Research; IBD; Inflammatory Bowel Disease; Ulcerative Colitis
Authors: John G Williams; M Fasihul Alam; Laith Alrubaiy; Clare Clement; David Cohen; Michelle Grey; Mike Hilton; Hayley A Hutchings; Mirella Longo; Jayne M Morgan; Frances L Rapport; Anne C Seagrove; Alan Watkins Journal: Health Technol Assess Date: 2016-06 Impact factor: 4.014
Authors: David Laharie; Arnaud Bourreille; Julien Branche; Matthieu Allez; Yoram Bouhnik; Jerome Filippi; Frank Zerbib; Guillaume Savoye; Maria Nachury; Jacques Moreau; Jean-Charles Delchier; Jacques Cosnes; Elena Ricart; Olivier Dewit; Antonio Lopez-Sanroman; Jean-Louis Dupas; Franck Carbonnel; Gilles Bommelaer; Benoit Coffin; Xavier Roblin; Gert Van Assche; Maria Esteve; Martti Färkkilä; Javier P Gisbert; Philippe Marteau; Stephane Nahon; Martine de Vos; Denis Franchimont; Jean-Yves Mary; Jean-Frederic Colombel; Marc Lémann Journal: Lancet Date: 2012-10-10 Impact factor: 79.321
Authors: Craig Mowat; Andrew Cole; Al Windsor; Tariq Ahmad; Ian Arnott; Richard Driscoll; Sally Mitton; Tim Orchard; Matt Rutter; Lisa Younge; Charlie Lees; Gwo-Tzer Ho; Jack Satsangi; Stuart Bloom Journal: Gut Date: 2011-05 Impact factor: 23.059
Authors: Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne Journal: Gut Date: 2019-09-27 Impact factor: 23.059
Authors: Manuel Barreiro-de Acosta; Ana Gutiérrez; Yamile Zabana; Belén Beltrán; Xavier Calvet; María Chaparro; Eugeni Domènech; Maria Esteve; Julian Panés; Javier P Gisbert; Pilar Nos Journal: United European Gastroenterol J Date: 2021-06-05 Impact factor: 6.866
Authors: Charlie W Lees; Shaji Sebastian; Nicholas A Kennedy; Richard Hansen; Lisa Younge; Joel Mawdsley; R Mark Beattie; Shahida Din; Christopher A Lamb; Philip J Smith; Christian Selinger; Jimmy Limdi; Tariq H Iqbal; Alan Lobo; Rachel Cooney; Oliver Brain; Daniel R Gaya; Charles Murray; Richard Pollok; Alexandra Kent; Tim Raine; Neeraj Bhala; James O Lindsay; Peter M Irving Journal: Frontline Gastroenterol Date: 2020-06-16
Authors: Peter Irving; Johan Burisch; Richard Driscoll; Mats Olsson; John R Fullarton; Barry S Rodgers-Gray; Simon Pl Travis Journal: Intest Res Date: 2018-10-10